Autoimmune and inflammatory manifestations in pediatric patients with primary immunodeficiencies and their importance as a warning sign
Main Article Content
Keywords
Primary immunodeficiency, Autoimmunity, Inflammation
Abstract
Introduction and objectives: As well as increased susceptibility to infections, autoimmune and inflammatory manifestations also eventuate due to dysregulation of immune system in a substantial proportion of patients with primary immunodeficiency (PID). Autoimmune and inflammatory manifestations can occur prior or after diagnosis of PID. This study aimed to evaluate autoimmune and inflammatory complications among all types of PID patients in childhood and to emphasize the importance of these findings as a warning sign to diagnose PIDs.
Methods: Medical records of 1036 patients with PID, followed up between 2003 and 2019, were retrospectively screened for occurrence of autoimmunity and inflammation. During this time, demographic features, autoimmune/inflammatory findings and initial time, genetic mutations, laboratory and clinical follow up findings, treatment regimens and outcomes were recorded.
Results: Autoimmune and inflammatory manifestations were observed in 83 patients (10.1%). The median age of autoimmunity initial time was 61.3 ± 53 months. Sixty-seven (80.7%) patients presented with autoimmune and inflammatory manifestations, and these findings had occurred during 16 patients’ (19.3%) follow-up. The most common autoimmune manifestations were autoimmune hematologic (51.8%) and endocrine diseases (26.5%). Fifty patients (60.2%) had a single autoimmune/inflammatory manifestation, however 23 patients (27.7%) had two, eight patients (9.6%) had three and two patients (2.4%) had four different types of autoimmune/inflammatory manifestations. The frequency of autoimmune and inflammatory manifestations in phagocyte defects (56%), combined immune deficiencies (53%) and immune dysregulation diseases (52%) were observed higher than other forms of PIDs. During follow-up 13 (15.7%) patients died.
Conclusion: Autoimmune/inflammatory manifestations are associated with high morbidity in patients with PIDs and may precede the diagnosis of PID in childhood. Therefore, physicians must be aware of underlying possible immune deficiency and patients with known PIDs should be evaluated for autoimmune and inflammatory complications.
References
2. Maggadottir SM, Sullivan KE. The intersection of immune deficiency and autoimmunity. Curr Opin Rheumatol. 2014;26:570-8, doi:10.1097/BOR.0000000000000091.
3. Arason GJ, Jorgensen GH, Ludviksson BR. Primary immunodeficiency and autoimmunity: lessons from human diseases. Scand J Immunol. 2010;71:317-28, http://dx.doi.org/10.1111/j.1365-3083.2010.02386.x.
4. Saifi M, Wysocki CA. Autoimmune disease in primary immunodeficiency: at the crossroads of anti-infective immunity and self-tolerance. Immunol Allergy Clin N Am. 2015;35:731-52, http://dx.doi.org/10.1016/j.iac.2015.07.007.
5. Azizi G, Ziaee V, Tavakol M, Alinia T, Yazdai R, Mohammadi H, et al. Approach to the management of autoimmunity in primary immunodeficiency. Scand J Immunol. 2017;85:13-29, http://dx.doi.org/10.1111/sji.12506.
6. European Society for Immunodeficiencies. Registry Working Party Diagnosis criteria. Available from: https://esid.org/WorkingParties/Registry-Working-Party/Diagnosis-criteria [accessed 22.1.16].
7. Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol. 2018;38:96-128, http://dx.doi.org/10.1007/s10875-017-0464-9.
8. World Health Organization. International statistical classification of diseases and related health problems, Tenth Revision. Geneva: World Health Organization; 1992.
9. Fischer A, Provot J, Jais JP, Alcais A, Mahlaoui N, members of the CEREDIH French PID study group. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2017;140:1388-93, http://dx.doi.org/10.1016/j.jaci.2016.12.978.
10. Pfajfer L, Mair NK, Jiménez-Heredia R, Genel F, Gulez N, Ardeniz Ö, et al. Mutations affecting the actin regulator WD repeat-containing protein 1 lead to aberrant lymphoid immunity. J Allergy Clin Immunol. 2018;142:1589-604.e11, http://dx.doi.org/10.1016/j.jaci.2018.04.023.
11. Girit S, Genel F, Can D, Bak M, Hershfield M. Case of purine nucleoside phosphorylase deficiency presented with hematuria. Open J Pediatr. 2012;2:268-71, http://dx.doi.org/10.4236/ojped.2012.24044.
12. Kara Ahu, Devrim Ilker, Bayram Nuri, Apa Hurs¸it, Genel Ferah. Abdominal tuberculosis in a child with interleukin-12 receptor beta 1 deficiency. Infect Dis Clin Pract. 2016;24:105, doi:10.1097/IPC.0000000000000304.
13. Nita IM, Genel F, Nilsson SC, Smart J, Truedsson L, Choo S, et al. Molecular characterization of two novel cases of complete complement inhibitor factor I deficiency. Mol Immunol. 2011;48:1068-72, http://dx.doi.org/10.1016/j.molimm.2011.01.012.
14. Genel F, Sjöholm AG, Skattum L, Truedsson L. Complement factor I deficiency associated with recurrent infections, vasculitis and immune complex glomerulonephritis. Scand J Infect Dis. 2005;37:615-8, http://dx.doi.org/10.1080/00365540510034536.
15. Genel F, Ozbek E, Ozek G, Vergin C, Ortac R, Santisteban I, et al. Adenosine deaminase-deficient severe combined immunodeficiency and diffuse large B-Cell lymphoma. Pediatr Allergy Immunol Pulmonol. 2015;28:138-42, http://dx.doi.org/10.3389/fimmu.2018.00113.
16. Karaca NE, Aksu G, Ulusoy E, Aksoylar S, Gozmen S, Genel F, et al. Early diagnosis and hematopoietic stem cell transplantation for IL10R deficiency leading to very early-onset inflammatory bowel disease are essential in familial cases. Case Reports Immunol. 2016, http://dx.doi.org/10.1155/2016/5459029.
17. Somekh I, Thian M, Medgyesi D, Gülez N, Magg T, Gallón Duque A, et al. CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis. Blood. 2019;134:1510-6, http://dx.doi.org/10.1182/blood.2019000644.
18. Gulez N, Genel F, Atlihan F, Gullstrand B, Skattum L, Schejbel L, et al. Homozygosity for a novel mutation in the C1q C chain gene in a Turkish family with hereditary C1q deficiency. J Investig Allergol Clin Immunol. 2010;20:255-8.
19. Blazina S, Markelj G, Jeverica AK, Toplak N, Brataniˇc N, Jazbec J, et al. Autoimmune and inflammatory manifestations in 247 patients with primary immunodeficiency --- a report from the Slovenian national registry. J Clin Immunol. 2016;36:764-73, http://dx.doi.org/10.1007/s10875-016-0330-1.
20. Lam DS, Lee TL, Chan KW, Ho HK, Lau YL. Primary immunodeficiency in Hong Kong and the use of genetic analysis for diagnosis. Hong Kong Med J. 2005;11:90-6.
21. Patiroglu T, Gungor HE, Unal E. Autoimmune diseases detected in children with primary immunodeficiency diseases: results from a reference centre at middle anatolia. Acta Microbiol Immunol Hung. 2012;59:343-53, http://dx.doi.org/10.1556/AMicr.59.2012.3.5.
22. Bjelac JA, Yonkof JR, Fernandez J. Differing performance of the warning signs for immunodeficiency in the diagnosis of pediatric versus adult patients in a two-center tertiary referral population. J Clin Immunol. 2019;39:90-8, http://dx.doi.org/10.1007/s10875-018-0582-z.
23. CEREDIH, French PID Study Group. The French National Registry of primary immunodeficiency disease. Clin Immunol. 2010;135:264-72, http://dx.doi.org/10.1016/j.clim.2010.02.021.
24. Azizi G, Tavakol M, Rafiemanesh H, Kiaee F, Yazdani R, Heydari A, et al. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies. Expert Rev Clin Immunol. 2017;13:1099-106, http://dx.doi.org/10.1080/1744666X.2017.1384312.
25. Quinti I, Soresina A, Spadaro G, Donnanno S, Agostini C, Claudio P, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27:308-16, http://dx.doi.org/10.1007/s10875-007-9075-1.
26. Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep. 2009;9:347-52, http://dx.doi.org/10.1016/j.anai.2019.07.014.
27. Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev. 2002;16:61-4, http://dx.doi.org/10.1054/blre.2001.0185.
28. Brandt D, Gershwin ME. Common variable immune deficiency and autoimmunity. Autoimmun Rev. 2006;5:465-70, http://dx.doi.org/10.1016/j.autrev.2006.03.010.
29. Knight AK, Cunningham-Rundle C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev. 2006;5:156-9, http://dx.doi.org/10.1016/j.autrev.2005.10.002.
30. Driessen GJ, Dalm VA, van Hagen PM, Grashoff HA, Hartwig NG, van Rossum AM, et al. Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrum. Haematologica. 2013;98:1617-23, http://dx.doi.org/10.3324/haematol.2013.085076.
31. Michel M, Chanet V, Galicier L, Ruivard M, Levy Y, Hermine O, et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore). 2004;83:254-63, http://dx.doi.org/10.1097/01.md.0000133624.65946.40.
32. Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun. 2005;25:57-62, http://dx.doi.org/10.1016/j.jaut.2005.04.006.
33. Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Ann Allergy Asthma Immunol. 2019, http://dx.doi.org/10.1016/j.anai.2019.07.014. PII: S1081-1206(19)30532-0.
34. Amaya-Uribe L, Rojas M, Azizi G, Anaya JM, Gershwin ME. Primary immunodeficiency and autoimmunity: a comprehensive review. J Autoimmun. 2019;99:52-72, http://dx.doi.org/10.1016/j.jaut.2019.01.011.
35. Baris¸ HE, Kıykım A, Nain E, Ozen AO, Karakoc-Aydiner E, Baris¸ S. The plethora, clinical manifestations and treatment options of autoimmunity in patients with primary immunodeficiency. Turk Pediatri Ars. 2016;51:186-92, http://dx.doi.org/10.5152/TurkPediatriArs.2016.3928.
36. Goyal R, Bulua AC, Nikolov NP, Schwartzberg PL, Siegel RM. Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders. Curr Opin Rheumatol. 2009;21:78-84, http://dx.doi.org/10.1097/BOR. 0b013e32831cb939.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.